Hallmark Capital Management Inc Vertex Pharmaceuticals Inc Transaction History

Hallmark Capital Management Inc

$1.31 Billion
Q4 2024

A detailed history of Hallmark Capital Management Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Hallmark Capital Management Inc holds 50,524 shares of VRTX stock, worth $25.9 Million. This represents 1.55% of its overall portfolio holdings.

Number of Shares

50,524

Previous 50,474 0.1%

Holding current value

$25.9 Million

Previous $23.5 Million 13.33%

% of portfolio

1.55%

Previous 1.77%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	BUY	$396.64 - $516.74 $19,832 - $25,837	50 Added 0.1%	50,524 $20.3 Million
Q3 2024 Nov 06, 2024	SELL	$460.0 - $505.78 $462,760 - $508,814	-1,006 Reduced 1.95%	50,474 $23.5 Million
Q2 2024 Aug 08, 2024	SELL	$392.81 - $485.53 $1.46 Million - $1.81 Million	-3,723 Reduced 6.74%	51,480 $24.1 Million
Q1 2024 May 03, 2024	SELL	$407.69 - $446.08 $1.67 Million - $1.83 Million	-4,093 Reduced 6.9%	55,203 $23.1 Million
Q4 2023 Feb 07, 2024	SELL	$343.0 - $410.68 $548,800 - $657,088	-1,600 Reduced 2.63%	59,296 $24.1 Million
Q3 2023 Nov 09, 2023	SELL	$338.18 - $362.46 $1.07 Million - $1.15 Million	-3,170 Reduced 4.95%	60,896 $21.2 Million
Q2 2023 Jul 28, 2023	SELL	$314.42 - $351.91 $1.34 Million - $1.5 Million	-4,268 Reduced 6.25%	64,066 $22.5 Million
Q1 2023 May 03, 2023	SELL	$283.23 - $323.1 $1.11 Million - $1.26 Million	-3,913 Reduced 5.42%	68,334 $21.5 Million
Q4 2022 Feb 01, 2023	SELL	$285.76 - $321.48 $1.97 Million - $2.21 Million	-6,879 Reduced 8.69%	72,247 $20.9 Million
Q3 2022 Nov 09, 2022	SELL	$273.83 - $305.53 $1.83 Million - $2.05 Million	-6,699 Reduced 7.81%	79,126 $22.9 Million
Q2 2022 Nov 16, 2022	BUY	$234.96 - $292.55 $1.57 Million - $1.96 Million	6,699 Added 8.47%	85,825 $24.2 Million
Q2 2022 Aug 01, 2022	SELL	$234.96 - $292.55 $1.1 Million - $1.37 Million	-4,678 Reduced 5.17%	85,825 $24.2 Million
Q1 2022 May 02, 2022	SELL	$221.42 - $260.97 $1.05 Million - $1.24 Million	-4,735 Reduced 4.97%	90,503 $23.6 Million
Q4 2021 Feb 02, 2022	SELL	$177.01 - $223.45 $199,136 - $251,381	-1,125 Reduced 1.17%	95,238 $20.9 Million
Q3 2021 Nov 01, 2021	BUY	$181.39 - $202.99 $17.5 Million - $19.6 Million	96,363 New	96,363 $17.5 Million

Others Institutions Holding VRTX

# of Institutions

1,763

Shares Held

228M

Call Options Held

1.63M

Put Options Held

1.47M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $131B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hallmark Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hallmark Capital Management Inc with notifications on news.

Account

Hallmark Capital Management Inc Vertex Pharmaceuticals Inc Transaction History